Showing 331-340 of 500 results for "".
Coming & Going: July/August 2021
https://modernaesthetics.com/topics/energy-based-devices/coming-going-julyaugust-2021/35068/Coming & Going: November/December 2020
https://modernaesthetics.com/ma-issues-index/2020-nov-dec/coming-going-novemberdecember-2020/34979/Coming & Going
https://modernaesthetics.com/topics/skincare/coming-going/33963/Coping with COVID-19: Multidisciplinary Panel Offers Counsel on Reopening
https://modernaesthetics.com/topics/minimally-invasive/coping-with-covid-19-multidisciplinary-panel-offers-counsel-on-reopening/34892/Reimagining Menopause with Hormones and Longevity
https://modernaesthetics.com/ma-issues-index/jan-feb-2026-issue/reimagining-menopause-with-hormones-and-longevity/54435/Insurance Ramifications for Medical Directors of Med Spas
https://modernaesthetics.com/ma-issues-index/2014-may-june/insurance-ramifications-for-medical-directors-of-med-spas/34627/In addition to general legal considerations, Med Spa Directors need to think about insurance ramifications.Evolving Perspectives: The Aesthetics Mergers & Acquisitions Market Today
https://modernaesthetics.com/ma-issues-index/2023-july-aug/evolving-perspectives-the-aesthetics-mergers-acquisitions-market-today/35301/A survey of some of the most seasoned buyers and experts in the industry gathers their sentiments on the industry, mergers and acquisitions (M&A) activity, and the state of the economy today.Measuring Your Cost Per Lead: It’s So 2019
https://modernaesthetics.com/topics/practice-development/measuring-your-cost-per-lead-its-so-2019/35167/How to assign truly meaningful data about the cost of each bookingLessons from HBO's Docuseries The Defiant Ones
https://modernaesthetics.com/ma-issues-index/2017-sept-oct/lessons-from-hbos-docuseries-the-defiant-ones/34239/How Dr. Dre and Jimmy Iovine disrupted an industry and made billions.Navigating Daxxify’s Potential in the Aesthetic Landscape
https://modernaesthetics.com/topics/injectables/navigating-daxxifys-potential-in-the-aesthetic-landscape/35294/Daxxify’s recent FDA approval provides practitioners with a neuromodulator option possessing a unique formulation and long-lasting results.